Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (FY)Mar 31, 2025 | (FY)Mar 31, 2024 | (Q4)Mar 31, 2024 | (Q3)Dec 31, 2023 | (Q2)Sep 30, 2023 | (Q1)Jun 30, 2023 | (FY)Mar 31, 2023 | (Q4)Mar 31, 2023 | (Q3)Dec 31, 2022 | (Q2)Sep 30, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 12.86%6.7B | 22.12%5.94B | 34.75%1.82B | 17.93%1.47B | 12.67%1.35B | 21.62%1.29B | 20.68%4.86B | 26.92%1.35B | 20.03%1.25B | 20.12%1.2B |
| Cost of revenue | 19.90%2.03B | 23.46%1.69B | 50.61%597M | 17.69%411.69M | 6.46%353.95M | 12.79%326.79M | 15.02%1.37B | 27.33%396.39M | 9.82%349.8M | 15.48%332.48M |
| Gross profit | 10.06%4.68B | 21.59%4.25B | 28.18%1.23B | 18.03%1.06B | 15.05%995.22M | 24.93%965.59M | 23.05%3.49B | 26.75%956.03M | 24.53%900.01M | 22.00%865.02M |
| Operating expense | 33.81%3.91B | -16.09%2.92B | -22.91%765.14M | -12.50%727.45M | -16.34%703.8M | -11.25%727.81M | 13.12%3.49B | 1.42%992.48M | 7.22%831.37M | 21.27%841.22M |
| Operating profit | -42.39%762.92M | 14,848.59%1.32B | 1,362.67%460.28M | 387.81%334.81M | 1,124.16%291.42M | 604.54%237.79M | 103.67%8.86M | 83.75%-36.45M | 230.39%68.64M | 54.99%23.81M |
| Net non-operating interest income (expenses) | 272.25%596K | 4.95%-346K | -108.06%-258K | 71.64%-19K | 67.11%-25K | 54.64%-44K | 37.56%-364K | -24.00%-124K | 67.16%-67K | 40.16%-76K |
| Non-operating interest income | 845.60%1.83M | 672.00%193K | 1,670.00%177K | 33.33%4K | 0.00%10K | 0.00%2K | -13.79%25K | -23.08%10K | 50.00%3K | -16.67%10K |
| Non-operating interest expense | 128.01%1.23M | 72.20%539K | 650.00%435K | -67.14%23K | -59.30%35K | -53.54%46K | -40.83%313K | -48.67%58K | -43.09%70K | -38.13%86K |
| Total other finance cost | ---- | ---- | ---- | ---- | ---- | ---- | -8.43%76K | ---- | ---- | ---- |
| Net investment income | 5.38%196K | 5.08%186K | 5.68%93K | 0 | 113.25%177K | 88K | 0 | 88K | ||
| Gain(Loss) on financial instruments designated as cash flow hedges | ||||||||||
| Gain(Loss) on derecognition of available-for-sale financial assets | 33.27%-32.04M | -323.76%-48.02M | -233.22%-28.55M | -405K | 48.62%-11.33M | 7.92%-8.57M | 0 | |||
| Income from associates and other participating interests | ||||||||||
| Special income (charges) | 51.35%-65.7M | -135.03M | 0 | 0 | ||||||
| Less:Write off | -51.35%65.7M | --135.03M | ---- | ---- | ---- | ---- | --0 | ---- | ---- | ---- |
| Other non-operating income (expenses) | 135.22%30.31M | 49.22%12.89M | -47.04%367K | 170.43%1.39M | 345.36%449K | 40.31%10.68M | -56.49%8.64M | 1,258.82%693K | -63.70%514K | -535.71%-183K |
| Income before tax | -39.66%696.29M | 19,210.21%1.15B | 769.21%296.9M | 386.05%335.77M | 1,172.12%272.88M | 718.10%248.42M | 102.37%5.98M | 80.93%-44.37M | 210.89%69.08M | 70.94%21.45M |
| Income tax | -45.10%238.21M | 742.74%433.87M | 1,291.93%128.51M | 242.87%111.51M | 350.63%102.33M | 1,200.91%91.52M | 127.47%51.48M | 96.11%-10.78M | 555.62%32.52M | -59.59%22.71M |
| Net income | -36.39%458.07M | 1,682.41%720.11M | 601.38%168.39M | 513.38%224.27M | 13,668.34%170.55M | 432.23%156.9M | 29.34%-45.51M | -175.66%-33.59M | 166.28%36.56M | 97.12%-1.26M |
| Net income continuous operations | -36.39%458.07M | 1,682.42%720.11M | 601.40%168.39M | 513.41%224.26M | 13,668.34%170.55M | 432.24%156.9M | 29.34%-45.51M | -175.66%-33.58M | 166.28%36.56M | 97.12%-1.26M |
| Noncontrolling interests | ||||||||||
| Net income attributable to the company | -36.39%458.07M | 1,682.41%720.11M | 601.38%168.39M | 513.38%224.27M | 13,668.34%170.55M | 432.23%156.9M | 29.34%-45.51M | -175.66%-33.59M | 166.28%36.56M | 97.12%-1.26M |
| Preferred stock dividends | ||||||||||
| Other under preferred stock dividend | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net income attributable to common stockholders | -36.39%458.07M | 1,682.41%720.11M | 601.38%168.39M | 513.38%224.27M | 13,668.34%170.55M | 432.23%156.9M | 29.34%-45.51M | -175.66%-33.59M | 166.28%36.56M | 97.12%-1.26M |
| Gross dividend payment | ||||||||||
| Basic earnings per share | -36.41%16.55 | 1,682.22%26.0275 | 600.82%6.085 | 511.51%8.1025 | 13,800.00%6.165 | 431.87%5.675 | 29.78%-1.645 | -175.12%-1.215 | 166.17%1.325 | 97.17%-0.045 |
| Diluted earnings per share | -36.41%16.55 | 1,682.22%26.0275 | 600.73%6.0839 | 513.16%8.1025 | 13,664.53%6.1625 | 431.58%5.67 | 29.78%-1.645 | -175.63%-1.215 | 165.99%1.3214 | 97.15%-0.0454 |
| Dividend per share | 2.5 | |||||||||
| Currency Unit | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY |
| Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |